Trevena Announces FDA Acceptance for Review of New Drug Application for Olinvo (oliceridine) Injection

8 years ago

by David Miller

968 Views

Written by David Miller

January 2, 2018 — Trevena, Inc. (NASDAQ:TRVN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for Olinvo (oliceridine) Injection. The Company expects that the PDUFA date for…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!